ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.

Boris Freidlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.